Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsPrabhat agrawal

    Prabhat Agrawal

    Jump to

    • Alkem to market Tiger Balm range of products in India

      "The Mumbai-based company has entered into an alliance with Haw Par India, a wholly-owned subsidiary of Singapore's Haw Par Healthcare, to exclusively market and distribute Tiger Balm range of products in the country," Alkem Labs said in a regulatory filing.

    • Alkem Labs Q2 net inches up 6% to Rs 283 cr

      Drug firm Alkem Laboratories today reported a 5.96 per cent rise in its consolidated net profit to Rs 282.83 crore for the quarter to September, mainly on back of robust sales.

    • Alkem Laboratories Q1 net up 17.12% at Rs 238.79 cr

      The company had posted a consolidated net profit of Rs 203.87 crore in the same quarter last fiscal, Alkem Laboratories said in a BSE filing.

    • See FY17 margin at 17% with downside pressure: Alkem Labs

      The company will work towards increasing volumes in the gastro-intestinal, anti-diabetic and cardio segments, among others, to overcome margin pressures due to industry headwinds, says Prabhat Agrawal, CEO of Alkem Laboratories.

    • Good demand from anchor investors for IPO: Alkem Labs

      Alkem is looking to raise around Rs 1300 crore through its IPO by offering 1.28 crore shares in a price band of Rs 1020-1050. The entire issue is an offer for sale by existing shareholders.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347